Interpreting Key Trials
Is niacin ineffective? Or did AIM-HIGH miss its target?
Stephen J. Nicholls, MBBS, PhD
Cleveland Clinic Journal of Medicine January 2012, 79 (1) 38-43; DOI: https://doi.org/10.3949/ccjm.79a.11166
Stephen J. Nicholls
Assistant Professor of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Cardiovascular Director, Cleveland Clinic Coordinating Center for Clinical Research, Heart and Vascular Institute, Cleveland Clinic
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 79, Issue 1
1 Jan 2012
Is niacin ineffective? Or did AIM-HIGH miss its target?
Stephen J. Nicholls
Cleveland Clinic Journal of Medicine Jan 2012, 79 (1) 38-43; DOI: 10.3949/ccjm.79a.11166
Jump to section
Related Articles
- No related articles found.
Cited By...
- Measuring niacin-associated skin toxicity (NASTy) stigmata along with symptoms to aid development of niacin mimetics
- In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I
- Function and Distribution of Apolipoprotein A1 in the Artery Wall Are Markedly Distinct From Those in Plasma
- HDL and Cardiovascular Risk: Time to Call the Plumber?